Baxter has received US FDA approval of an expanded indication for Clinolipid (lipid injectable emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is a proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated. The product contains 20% soybean oil and 80% olive oil. Clinolipid is rich in omega-9 oleic acid, can minimize the decline in post-natal arachidonic acid levels, and is supported by PN admixture stability.